Evidence map›Paper›PMID 37033359›Full record

ArticleTranslational cancer research2023

Unusual presentation of a neuroendocrine tumor in the ileostomy specimen after rectal cancer treatment: a case report.

Leonardo Alfonso Bustamante-Lopez, Ahmed Allawi, David Yu, Liam Devane, Justin Kelly, Norbert Garcia-Henriquez, John R T Monson

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leonardo Alfonso Bustamante-LopezSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
Ahmed AllawiSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
David YuSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
Liam DevaneSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
Justin KellySurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
Norbert Garcia-HenriquezSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
John R T MonsonSurgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth, Orlando, FL, USA.
AdventHealth Orlando · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neuroendocrine tumors of the small intestine are uncommon, but at the same time they are the most frequent subtype of neuroendocrine tumor in the gastrointestinal system. They originate from enterochromaffin cells, which are involved in the creation of serotonin. This asymptomatic characteristic in the initial presentation is usually why these tumors are discovered at a late stage, sometimes in association with symptomatic metastatic disease. Case Description: We present a case-report of a 52-year-old gentleman with a suggestive family history of hereditary cancer syndrome (mother with lung cancer and maternal uncle with colon cancer at the age of 40 years old). The patient was diagnosed with rectal cancer and he received neoadjuvant chemotherapy with short-course radiotherapy followed by a robotic low anterior resection with diverting loop ileostomy. Following closure of his ileostomy, the pathology report of the ileostomy resection specimen showed a 1.1 cm neuroendocrine tumor with negative margins. Conclusions: This extraordinary unusual presentation could be very fortuity for the patient, who in every other opportunity just found this neuroendocrine tumor after advanced or maybe metastatic diseases.

Indexed as

case reportileostomyneuroendocrine tumorRectal cancersmall bowel neuroendocrine

Identifiers

PMID37033359
PMCPMC10080463
OpenAlexW4360982256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.